Company: SLNH
Filing Date: 2025-04-25
Form Type: 424B3
Source: 0001641172-25-006194
Chunk: 3

Company: Soluna Holdings, Inc
Filing Date: 2025-04-25
Form: 424B3
Chunk 3
---
ers and the shares of Common Stock that may be issued by us are collectively referred to in this prospectus as the “Offered
Securities.” We will not receive any of the proceeds from the sale by the Selling Holders of the Offered Securities.

We will bear all costs, expenses and fees in connection
with the registration of Offered Securities. The Selling Holders will bear all commissions and discounts, if any, attributable to their
respective sales of Offered Securities. We are registering certain shares of our Common Stock for sale by the Selling Holders pursuant
to various registration rights agreements with the Selling Holders. See the section of this prospectus entitled “Selling Holders”
for more information.

The Investor is an “underwriter” within
the meaning of Section 2(a)(11) of the Securities Act and any profits on the sales of shares of our Common Stock by the Investor and any
discounts, commissions, or concessions received by the Investor are deemed to be underwriting discounts and commissions under the Securities
Act.

The Selling Holders may offer and sell the securities
covered by this prospectus from time to time. The Selling Holders may offer and sell the securities covered by this prospectus in a number
of different ways and at varying prices. If any underwriters, dealers or agents are involved in the sale of any of the securities, their
names and any applicable purchase price, fee, commission or discount arrangement between or among them will be set forth, or will be calculable
from the information set forth in a post-effective amendment to the registration statement of which this prospectus forms a part. See
the sections of this prospectus titled “About this Prospectus” and “Plan of Distribution” for more
information. No securities may be sold without delivery of this prospectus and any applicable prospectus supplement describing the method
and terms of the offering of such securities. We will file a prospectus supplement or post-effective amendment, as applicable, with any
information regarding any permitted transferees of the Selling Holders when such transferees become identifiable. You should carefully
read this prospectus and any applicable prospectus supplement before you invest in our securities.

Our Common Stock and our 9.0% Series A Cumulative
Perpetual Preferred Stock, par value $0.001 per share (the “Series A Preferred Stock”), are listed on Nasdaq under the symbols
“SLNH” and “SLNHP”, respectively. On April 17,